PIRS - Pieris Pharmaceuticals' (PIRS) CEO Steve Yoder on Q1 2020 Results - Earnings Call Transcript
Pieris Pharmaceuticals, Inc. (PIRS)
Q1 2020 Earnings Conference Call
May 11, 2020 8:00 AM ET
Company Participants
Tom Bures – Vice President of Finance
Steve Yoder - President and Chief Executive Officer
Ingmar Bruns – Senior Vice President and Head of Clinical Development
Hitto Kaufmann - Senior Vice President and Chief Scientific Officer
Shane Olwill – Senior Vice President and Head of Translational Science
Conference Call Participants
Jonathan Miller – Evercore ISI
Chang Liu – Jefferies
Madhu Kumar – Baird
Chris Shibutani – Cowen
Matt Phipps – William Blair
Presentation
Operator
Greetings, and welcome to